BKMEDIUM SIGNALFINANCIAL10-K

BNY Mellon delivered strong financial performance with 22.5% net income growth while significantly reducing share count through aggressive capital returns.

The company demonstrates robust operational execution with meaningful earnings growth alongside substantial shareholder capital returns through buybacks. The removal of AI-related risk language suggests either improved confidence in managing these risks or a shift in disclosure priorities, which warrants monitoring.

Comparing 2026-02-25 vs 2025-02-27View on EDGAR →
FINANCIAL ANALYSIS

BNY Mellon reported exceptionally strong financial performance with net income surging 22.5% to $5.5B, supported by a 14.6% increase in deposits to $331.9B and proportional asset growth to $472.3B. The company maintained an aggressive capital return strategy with share buybacks increasing 15.4% to $3.5B, contributing to a 4.1% reduction in outstanding shares from 716M to 687M. The balanced growth in assets, liabilities, and deposits combined with strong profitability and cash generation signals healthy business momentum and effective capital allocation.

FINANCIAL STATEMENT CHANGES
Net Income
P&L
+22.5%
$4.5B→$5.5B

Net income grew 22.5% — bottom-line growth signals improving overall business health.

Cash & Equivalents
Balance Sheet
+22.3%
$4.2B→$5.1B

Cash grew 22.3% — improving liquidity position supports investment and shareholder returns.

Share Buybacks
Cash Flow
+15.4%
$3.1B→$3.5B

Share repurchases increased 15.4% — management returning capital, signals confidence in intrinsic value.

Total Deposits
Balance Sheet
+14.6%
$289.5B→$331.9B

Deposits grew 14.6% — expanding customer base or increased trust in the institution.

Total Liabilities
Balance Sheet
+14.2%
$374.3B→$427.5B

Liabilities increased 14.2% — monitor debt-to-equity ratio and interest coverage.

Total Assets
Balance Sheet
+13.5%
$416.1B→$472.3B

Asset base grew 13.5% — expansion through organic growth, acquisitions, or capital deployment.

LANGUAGE CHANGES
NEW — 2026-02-25
PRIOR — 2025-02-27
ADDED
As of January 31, 2026, 686,907,398 shares of the registrant s common stock, $0.01 par value per share, were outstanding.
BUSINESS Description of Business The Bank of New York Mellon Corporation, a Delaware corporation (NYSE symbol: BK), is a global financial services platforms company headquartered in New York, New York, with $59.3 trillion in assets under custody and/or administration and $2.2 trillion in assets under management as of Dec.
Thrive Together Our culture is an important part of what makes BNY successful.
We want the best people to work here, and to contribute to our success, regardless of their background.
Creating an environment where everyone belongs is essential that s how we succeed.
+7 more — sign up free →
REMOVED
As of January 31, 2025, 716,320,652 shares of the registrant s common stock, $0.01 par value per share, were outstanding.
Any such incident or failure could adversely impact our ability to conduct our businesses, damage our reputation and cause losses; the development and use of artificial intelligence present risks and challenges that may adversely impact our business; we are subject to extensive government rulemaking, policies, regulation and supervision that impact our operations.
BUSINESS Description of Business The Bank of New York Mellon Corporation, a Delaware corporation (NYSE symbol: BK), is a global company headquartered in New York, New York, with $52.1 trillion in assets under custody and/or administration and $2.0 trillion in assets under management as of Dec.
Belonging Belonging is integral to who we are as a company, what our people experience as members of our global team, and how we serve all of our stakeholders.
Our strategy is not separate, it includes all of our employees and is embedded in the way we do business, our operating model, talent experience and client value proposition.
+7 more — sign up free →
MORE FINANCIAL SIGNALS
CRMHIGHSalesforce significantly increased debt by 71% to $14.4B while simultaneously ac...
2026-03-02
UNHHIGHUNH's operating income plummeted 41% despite 12% revenue growth, indicating seve...
2026-03-02
PFEHIGHPfizer achieved a dramatic 87.3% reduction in total debt from $31.4B to $4.0B, r...
2026-02-26
GILDHIGHGILD dramatically increased R&D spending by 81.5% to $9.1B while introducing new...
2026-02-24
ANALYZE ANY FILING FREE

See what changed in your portfolio's filings

500+ US-listed companies analyzed. Language delta, financial analysis, instant signal scoring.

Try Tracenotes free →